Berlin-based NaturalX Health Ventures has unveiled a €100 million fund dedicated to consumer health startups, making it the first fund in Europe focused on bridging healthcare and consumer wellness.
The fund will support Series A-stage companies, with the flexibility to invest in late-seed and Series B rounds.
Investing in the Future of Consumer-Centric Healthcare
NaturalX Health Ventures aims to transform healthcare by investing in startups focused on:
- Mental health solutions
- Gut health and longevity
- Preventive healthcare and sleep technologies
Marvin Amberg, Founder of NaturalX Health Ventures, emphasized the growing demand for consumer-driven health solutions:
“Consumers are taking charge of their own health like never before. We see this as an inflection point in Europe, where the consumer health space has been historically overlooked by investors.”
Advertisement
Investment Strategy & Portfolio
- Investment size: €3M – €5M per startup, with up to €10M for high-growth companies
- Geographic focus: Primarily Europe, with selective investments in North America
- Role: Can act as a lead or co-investor
The fund is already operational and expanding its investment team across Europe.
Existing Portfolio & Market Opportunity
NaturalX has already invested in:
- Mybacs – A microbiome-focused health startup
- Flow Neuroscience – A mental health technology company
- Kyan Health – Personalized corporate wellness solutions
- Meela – AI-powered mental health therapy matching
Amberg noted that Europe is following trends seen in the U.S., where companies like Oura and Neko Health have demonstrated strong consumer demand for proactive health solutions.
Backing from Schwabe Group
NaturalX is supported by Schwabe Group, a 150-year-old pharmaceutical company specializing in plant-based medicines. The group, which generates €950 million in revenue, has a strong global presence across Europe, North America, and Asia.
With this €100M fund, NaturalX Health Ventures is positioning itself at the forefront of Europe’s consumer health revolution, driving investment into science-backed wellness and digital healthcare solutions.
